These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3544181)

  • 1. Pirenzepine in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.
    Niemelä S; Jääskeläinen T; Lehtola J; Martikainen J; Krekelä I; Sarna S; Sarelin H
    Scand J Gastroenterol; 1986 Dec; 21(10):1193-9. PubMed ID: 3544181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis.
    Londong W; Phillips J; Johnson NJ; Wood JR
    Aliment Pharmacol Ther; 1992 Oct; 6(5):609-18. PubMed ID: 1420752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study.
    Lehtola J; Niemelä S; Martikainen J; Krekelä I
    Scand J Gastroenterol; 1986 Mar; 21(2):175-80. PubMed ID: 3520796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis.
    Weberg R; Berstad A
    Scand J Gastroenterol; 1989 May; 24(4):401-6. PubMed ID: 2675302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre study.
    Farup PG; Weberg R; Berstad A; Wetterhus S; Dahlberg O; Dybdahl J; Fyllingen G; Kannelønning KS; Lange OJ
    Scand J Gastroenterol; 1990 Mar; 25(3):315-20. PubMed ID: 2181623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial.
    Grove O; Bekker C; Jeppe-Hansen MG; Karstoft E; Sanchez G; Axelsson CK; Nielsen HO; Andersen B; Rask-Madsen J
    Scand J Gastroenterol; 1985 May; 20(4):457-61. PubMed ID: 3895381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose antacids and pirenzepine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomized, double-blind, placebo-controlled trial.
    Weberg R; Berstad A
    Scand J Gastroenterol; 1988 Mar; 23(2):237-43. PubMed ID: 3283918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.
    Hine KR; Holmes GK; Melikian V; Lucey M; Fairclough PD
    Digestion; 1984; 29(2):119-23. PubMed ID: 6329862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
    Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB
    Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis.
    Graham DY; Patterson DJ
    Dig Dis Sci; 1983 Jun; 28(6):559-63. PubMed ID: 6345111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.
    Galmiche JP; Brandstätter G; Evreux M; Hentschel E; Kerstan E; Kratochvil P; Reichel W; Schütze K; Soule JC; Vitaux J
    Gut; 1988 May; 29(5):675-81. PubMed ID: 3294124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of childhood peptic oesophagitis with famotidine or alginate-antacid.
    Oderda G; Dell'Olio D; Forni M; Farina L; Tavassoli K; Ansaldi N
    Ital J Gastroenterol; 1990 Dec; 22(6):346-9. PubMed ID: 2131953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cimetidine in the treatment of reflux oesophagitis.
    Brown P
    Med J Aust; 1979 Jul; 2(2):96-7. PubMed ID: 386063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins in the treatment of reflux oesophagitis: double-blind placebo controlled clinical trial.
    Purushotham AD; Gray GR; Hansell DT
    J R Coll Surg Edinb; 1991 Aug; 36(4):216-8. PubMed ID: 1941733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine and placebo in the treatment of reflux oesophagitis. A double-blind randomized trial.
    Goy JA; Maynard JH; McNaughton WM; O'Shea A
    Med J Aust; 1983 Nov; 2(11):558-61. PubMed ID: 6314107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cimetidine and ranitidine in the treatment of reflux esophagitis].
    Kimmig JM
    Z Gastroenterol; 1984 Aug; 22(8):373-8. PubMed ID: 6091353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisapride for gastro-oesophageal reflux and peptic oesophagitis.
    Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S
    Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirenzepine and cimetidine for duodenal ulcers. A comparative randomised double-blind controlled study.
    Simjee AE; Bhoola RL; Spitaels JM; Manion GL
    S Afr Med J; 1988 Nov; 74(9):446-7. PubMed ID: 3055362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
    Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L
    Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.